How have Pactiv Evergreen Inc. (PTVE)’s performance and profitability changed over the time?

At the time of writing, Pactiv Evergreen Inc. [PTVE] stock is trading at $11.47, up up 14.47%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PTVE shares have gain 11.25% over the last week, with a monthly amount glided 22.54%, and seem to be holding up well over a long-time horizon.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

On 3, August 2022, Pactiv Evergreen Inc. Declares Quarterly Dividend. In a post published today on Yahoo Finance, Pactiv Evergreen Inc. (NASDAQ: PTVE) today announced that its board of directors has approved the payment of a quarterly dividend of $0.10 per share of common stock. The dividend will be paid on September 15, 2022 to shareholders of record at the close of business on August 31, 2022.

From an analyst’s perspective:

Pactiv Evergreen Inc. [NASDAQ: PTVE] stock has seen the most recent analyst activity on May 23, 2022, when Citigroup downgraded its rating to a Neutral and also revised its price target to $10 from $12. Previously, RBC Capital Mkts upgraded its rating to Outperform on May 06, 2022, and elevated its price target to $13. On April 14, 2022, downgrade downgraded it’s rating to Neutral but maintained its price target of $13 on the stock. Deutsche Bank upgraded its rating to a Buy and decreased its price target to $15 on December 20, 2021. BofA Securities upgraded its rating to a Buy. Mizuho started tracking with a Buy rating for this stock on October 13, 2021, and assigned it a price target of $16. In a note dated September 30, 2021, BMO Capital Markets upgraded an Outperform rating on this stock but restated the target price of $16.

For the past year, the stock price of Pactiv Evergreen Inc. fluctuated between $8.71 and $15.53. Currently, Wall Street analysts expect the stock to reach $11.84 within the next 12 months. Pactiv Evergreen Inc. [NASDAQ: PTVE] shares were valued at $11.47 at the most recent close of the market. An investor can expect a potential return of 3.23% based on the average price forecast.

Analyzing the PTVE fundamentals

According to Pactiv Evergreen Inc. [NASDAQ:PTVE], the company’s sales were 1.5 billion in the recent quarter, which represents an 28.40% jump. Gross Margin for this corporation currently stands at +9.10% with Operating Margin at +1.99%, Pretax Margin comes in at +0.53%, and Net Margin reading is +0.57%.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.89 points at the first support level, and at 10.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.92, and for the 2nd resistance point, it is at 12.36.

Pactiv Evergreen Inc. [PTVE] reported earnings per share of $0.24 for its fiscal quarter that ended on 3/30/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.11/share, meaning a difference of $0.13 and a surprise factor of 118.20%. By comparison, the stated earnings for the previous quarter ended on 12/30/2021 were $0.17 per share as compared to estimates of $0.43 per share, a difference of $-0.26 representing a surprise of -60.50%.

Ratios To Look Out For

It is important to note that Pactiv Evergreen Inc. [NASDAQ:PTVE] has a current ratio of 2.20. In addition, the Quick Ratio stands at 1.23 and the Cash Ratio stands at 0.24. Considering the valuation of this stock, the price to sales ratio is 0.41, the price to book ratio is 1.75 and the P/E (TTM) ratio is 23.75.

Transactions by insiders

In the past 3 months, 10 insiders have purchased 172,615 shares, and 1 have sold 12,352 shares. Recent insider trading involved Stangl Rolf, Director, that happened on Jun 16 when 5000.0 shares were purchased. Director, Hugli Allen completed a deal on Jun 16 to buy 2900.0 shares. Meanwhile, Director Hugli Allen bought 159.0 shares on Jun 15.